News
Processa Pharmaceuticals
PCSA · NASDAQ
$1.79+$0.06 (+3.47%)TodayMarket closed ·
Prev close $1.73
Latest news
- NewsAvi Kapoor
Crude Oil Surges 7%; General Dynamics Posts Upbeat Earnings
- NewsAvi Kapoor
Dow Tumbles 400 Points; Procter & Gamble Shares Fall After Q4 Results
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREAS
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releaseGlobe Newswire
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference
- NewsAvi Kapoor
Why Penguin Solutions Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study
- NewsAvi Kapoor
Why MillerKnoll Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
Processa Pharma's Abstract, "Adaptive Phase 2/3 Study For PCS499 (499) In Patients With Focal Segmental Glomerulosclerosis (FSGS)", Accepted For Presentation At ASN Kidney Week 2025
- Press releaseGlobe Newswire
Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Press releaseGlobe Newswire
Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
- Press releaseGlobe Newswire
Processa Pharmaceuticals Provides Portfolio and Business Update
- NewsAvi Kapoor
Crude Oil Rises Sharply; Jabil Earnings Top Views
- Press releaseGlobe Newswire
Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering
- NewsAvi Kapoor
US Stocks Lower; Retail Sales Decline In May
- NewsHenry Khederian
Processa Pharmaceuticals (PCSA) Shares Soar 150% On Gastroparesis Drug Deal
- NewsAvi Kapoor
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday
- NewsAvi Kapoor
Nasdaq Down 1%; JetBlue Airways Shares Spike Higher
- NewsAvi Kapoor
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- NewsAvi Kapoor
Crude Oil Down 1%; Procter & Gamble Shares Fall After Q4 Results
- NewsAvi Kapoor
Dow Jumps 200 Points; Pfizer Earnings Top Views
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.